T-cell immunodeficiency syndrome
T-cell immunodeficiency syndrome encompasses a range of disorders characterized by a deficiency, absence, or dysfunction of T cells, which play a crucial role in the immune system. This condition can be classified as primary (congenital) or secondary (acquired). Primary T-cell immunodeficiency, often stemming from genetic defects, typically presents in infancy or early childhood with unusual and recurrent infections. In contrast, secondary T-cell immunodeficiency is more prevalent and can arise from factors such as chronic infections, malnutrition, malignancies, or certain medications.
The severity of these immunodeficiencies varies; conditions like severe combined immune deficiency (SCID) pose significant risks to health, often leading to life-threatening infections in infants. Diagnosis typically involves a series of tests to identify the underlying genetic issues and assess immune function. Treatment strategies are tailored to individual disorders and may include immunoglobulin replacement therapy, stem cell transplantation, and careful management of infections. Early detection and intervention are vital for improving outcomes, as many disorders can significantly impact lifespan and quality of life. Genetic counseling may be recommended for families with a history of these conditions to better understand risks and management options.
T-cell immunodeficiency syndrome
DEFINITION T-cell immunodeficiency syndrome refers to the group of immunodeficiencies that increase susceptibility to infection as a result of an immune system with deficient, absent, or defective T cells. This immunodeficiency can be expressed as a primary (congenital) or a secondary (acquired) disorder. Primary T-cell immunodeficiency results from autosomal or X-linked genetic defects.
Risk Factors
Secondary T-cell immunodeficiency is the most common and develops as a result of chronic infection, malnutrition, systemic disease, malignancy, or drug therapy. Although primary T-cell immunodeficiency is less common than secondary forms, they are rare genetic disorders and generally develop in infancy or early childhood accompanied by recurrent unusual infections.
Etiology and Genetics
Considering that T cells (a type of white blood cells) are the dominant type of lymphocytes in circulating blood, it is very likely that a significant T-cell deficiency usually may cause a decrease in the number of blood lymphocytes. Several genetic abnormalities may prevent T cells from identifying and destroying foreign or abnormal cells circulating in the body. An impaired T-cell immunity damages the immune system’s ability to protect the body against bacterial, viral, fungal, or cancer cells attacks. The two general reasons contributing to the development of T-cell immunodeficiency syndrome are either autosomal or X-linked gene disorders resulting from mutations or deletions. These hereditary genetic disorders give rise to partial or absolute defects in T-cell function resulting in a defective immune system at birth or early in life. The most common forms of T-cell immunodeficiency disorders are severe combined immune deficiency (SCID), X-linked lymphoproliferative syndrome, X-linked hyper-IgM immunodeficiency, hyper-IgE syndrome, DiGeorge syndrome, ataxia telangectasia, Nijmegen breakage syndrome, and Wiskott-Aldrich syndrome.
Severe combined immune deficiency (SCID or bubble boy syndrome) is the most serious immunodeficiency disorder. A mutation in the IL-2R gene of the X chromosome causes SCID. This results in low levels of antibodies (immunoglobulins) and no T cells. The severity of this deficiency results in the development of more serious infections with infants not growing or developing normally. Untreated children frequently die before the age of one.
In DiGeorge syndrome, a deletion of chromosome 22 results in a thymus gland absent or underdeveloped at birth. The fetus has heart, face, thymus, and parathyroid gland abnormalities. The X-linked lymphoproliferative syndrome (Duncan disease) is caused by mutations in the SHD2D1A gene of the X chromosome. It results in defective T cells and natural killer (NK) cells and is characterized by extreme sensitivity to Epstein-Barr (mononucleosis) virus infection, resulting in liver failure, immunodeficiency, and malignant lymphoma.
Hyper-IgM syndrome is an deficiency known by normal or elevated IgM levels and decreased levels or absence of other serum antibodies. It is caused by a mutation in the CD40LG gene of the X chromosome and leads into susceptibility to bacterial infections.
Hyper-IgE syndrome (Buckley or Job syndrome) is caused by a mutation in the STAT3 gene of chromosome 17, which results in high levels of IgE and normal levels of the other antibody classes. These patients suffer from chronic eczema, recurrent lung infections, weak bones, coarse facial features, and pus abscesses.
The mutation in the ATM gene of chromosome 11, results in ataxia telangiectasia (AT). AT is characterized by dilated capillaries, higher susceptibility to infections, body movement incoordination, and malignancy predisposition.
A mutation in the NBS1 gene located on chromosome 8 is responsible for the Nijmegen (Berlin) breakage syndrome, which is characterized by microcephaly, sinopulmonary infections, immunodeficiency, and high risk for lymphoma cancer. Because Wiskott-Aldrich syndrome is caused by mutation in the WAS gene on the X chromosome, immunodeficiencies are characterized by thrombocytopenia, eczema, and recurrent respiratory infections. There is abnormal antibody production and defective T-cell function, affecting boys only. There is a higher incidence of developing cancers such as lymphoma and leukemia.
Symptoms
A history of recurrent unusual infections might suggest T-cell immunodeficiency syndrome. Frequently, respiratory infections arise first and reappear, becoming severe and persistent and leading to complications. Generally, the earliest the symptoms in life arise in children, the more severe will be the T-cell immunodeficiency syndrome. Other different ailments may contrast or change based on the infections’ severity and length. Chronic diarrhea may cause infants or young children not to grow or develop (failure to thrive) due to weight loss.
Screening and Diagnosis
Doctors suspecting a primary T-cell immunodeficiency will run a battery of tests to identify the specific genetic abnormality, immunoglobulin levels, white blood microscopic irregularities, skin tests, number of circulating B and T cells, and proper B and T cell function. Upon physical examination, rashes, weight loss, chronic cough, hair loss, and/or enlarged spleen or liver may suggest a particular disorder to doctors based on disease-specific clinical manifestations. An early onset of recurring or unusual infections is a key determinant in identifying the type of immunodeficiency disorder. Adverse prognosis follows a delayed diagnosis. The particular form of infection will also help healthcare professionals pinpoint the T-cell immunodeficiency variant.
Treatment and Therapy
Symptoms suggest the type of genetic disorder, and treatment strategies are tailored to meet specific immunodeficiencies needs. Many patients will require prompt aggressive treatment. General guidelines for these patients include: periodic IV immunoglobulin replacement therapy, practicing excellent personal hygiene, avoiding undercooked food, drinking boiled water, and avoiding contact with infected people. SCID patients are kept in protected environments, preventing exposure to pathogens and are treated with antibiotics, antivirals, and antibodies. Bone marrow stem cell transplantation from an unaffected sibling matching the same tissue type is the only effective treatment for SCID. Thymus transplantation for DiGeorge syndrome patients can cure the immunodeficiency, and corrective heart surgery is done for severe heart conditions.
Prevention and Outcomes
Prevention and outcome strategies depend on the type of T-cell immunodeficiency disorder diagnosed and time of diagnosis. Some T-cell immunodeficiency syndromes shorten life span while others can be managed throughout life. When the disorder does not impair antibody production, vaccination is recommended only with killed viral and bacterial vaccines since live vaccines might cause disease in immunodeficient patients. There is no effective form of prevention; therefore, genetic testing and counseling should be provided to people with family history previously identified for these types of hereditary immunodeficiencies. Early diagnosis is critical in improving patient outcome since many children die young if untreated. The role of alert healthcare professionals to recognize T-cell immunodeficiency clinical findings can play an essential part confirming rapid accurate diagnosis, ultimately resulting in improved patient outcome.
Bibliography
Aghamohammadi, Asghar, and Nima Rezaei. Clinical Cases in Primary Immunodeficiency Diseases: A Problem-Solving Approach. New York: Springer, 2012. Print.
Bonilla, F. A., et al. “Practice Parameter for the Diagnosis and Management of Primary Immunodeficiency.” Annals of Allergy, Asthma & Immunology 94.5 Suppl 1 (May 2005): S1–63. Print.
Boztug, K., et al. “Multiple Independent Second-Site Mutations in Two Siblings with Somatic Mosaicism for Wiskott-Aldrich Syndrome.” Clinical Genetics 74 (2008): 68–74. Print.
Conley, Mary Ellen. “Antibody Deficiencies.” The Metabolic and Molecular Bases of Inherited Disease. Ed. Charles Scriver et al. 8th ed. New York: McGraw, 2001. Print.
Cooper, Megan A., Thomas L. Pommering, and Katalin Koranyi. “Primary Immunodeficiencies.” American Family Physician 68 (2003): 2001–8, 2011. Print.
Edgar, J. D. “T Cell Immunodeficiency.” Journal of Clinical Pathology 61 (2008): 988–93. Print.
Kingsmore, S. F., et al. “Identification of Diagnostic Biomarkers for Infection in Premature Neonates.” Molecular & Cellular Proteomics 7.10 (2008): 1863–75. Print.
Ochs, Hans D., C. I. Edvard Smith, and Jennifer Puck. Primary Immunodeficiency Diseases: A Molecular and Genetic Approach. New York: Oxford UP, 2014. Print.
Rich, Robert R. Clinical Immunology: Principles and Practice. 4th ed. London: Elsevier Saunders, 2013. Print. Schwartz, Robert A. "T-Cell Disorders." MedScape, 17 May 2024, emedicine.medscape.com/article/888372-overview?form=fpf. Accessed 5 Sept. 2024.